The simultaneous occurrence of primary hyperparathyroidism and pituitary adenoma is the most common MEN1 phenotype in patients with no mutations in MEN1 gene but the same clinical manifestations have been also described in patients with damaging variants in CDKN1B, the causative gene of the recently described MEN4 syndrome [10]. Here, MEN1 is linked to primary hyperparathyroidism.